Literature DB >> 3551054

Yersiniosis as a gastrointestinal disease.

R Leino, K Granfors, T Havia, R Heinonen, M Lampinen, A Toivanen.   

Abstract

Anti-yersinia antibodies were assessed in sera from 630 patients admitted to a department of surgery for acute abdominal disease, using an enzyme-linked immunosorbent assay (ELISA). In 21 patients a high concentration of yersinia antibodies confirmed recent yersinia infection. Eight patients had an appendicectomy performed; in all patients with antibodies against Y. enterocolitica 9 or Y. pseudotuberculosis IA a true appendicitis was found at operation. Two patients with Y. enterocolitica 3 antibodies had acute terminal ileitis and mesenterial lymphadenitis. In 4 patients a diagnosis of acute pancreatitis was established; 2 of these had cholecystitis. Two further patients had cholecystitis without pancreatic affection. Two patients had colonic diverticulitis, 1 with perforation. The results demonstrate that yersinia infection may commonly give rise to a variety of acute abdominal inflammations, and stress the importance of serological and bacteriological diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551054     DOI: 10.3109/00365548709032379

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.

Authors:  G Mazzoleni; D deSa; J Gately; R H Riddell
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

2.  Chronic fatigue, arthralgia, and malaise.

Authors:  M M Gompels; G P Spickett
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

3.  Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay.

Authors:  K Granfors; R Lahesmaa-Rantala; T H Ståhlberg; A Toivanen
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

4.  Clinical manifestations of Yersinia pseudotuberculosis infection in children.

Authors:  R Tertti; R Vuento; P Mikkola; K Granfors; A L Mäkelä; A Toivanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

5.  Human coproantibody secretory immunoglobulin A response to Yersinia species.

Authors:  K M Fletcher; C M Morris; M A Noble
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

6.  Causative role of Yersinia and other enteric pathogens in the appendicular syndrome.

Authors:  R Van Noyen; R Selderslaghs; J Bekaert; G Wauters; J Vandepitte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

7.  Yersinia pseudotuberculosis aortitis in a patient with diverticulosis and polycystic kidney disease.

Authors:  Sarah McCloskey; Philip Haslam; David A Price; John A Sayer
Journal:  Oxf Med Case Reports       Date:  2015-04-21

8.  The Cytotoxic Necrotizing Factor of Yersinia pseudotuberculosis (CNFy) is Carried on Extracellular Membrane Vesicles to Host Cells.

Authors:  Ajay K Monnappa; Wasimul Bari; Jeong Kon Seo; Robert J Mitchell
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.